blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2493478

EP2493478 - CONCENTRATED THERAPEUTIC PHOSPHOLIPID COMPOSITIONS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  30.12.2018
Database last updated on 11.09.2024
FormerThe patent has been granted
Status updated on  19.01.2018
FormerGrant of patent is intended
Status updated on  12.01.2018
FormerExamination is in progress
Status updated on  18.12.2017
FormerGrant of patent is intended
Status updated on  27.09.2017
FormerExamination is in progress
Status updated on  21.11.2016
Most recent event   Tooltip10.07.2020Lapse of the patent in a contracting state
New state(s): IS		published on 12.08.2020  [2020/33]
Applicant(s)For all designated states
Acasti Pharma, Inc.
545 Promenade du Centropolis, Suite 100
Laval, Quebec H7T 0A3 / CA
[2018/11]
Former [2018/08]For all designated states
Acasti Pharma, Inc.
225 Promenade Du Centropolis Suite 200
Laval, Quebec H7T 0B3 / CA
Former [2012/36]For all designated states
Acasti Pharma, Inc.
225 Promenade Du Centropolis Suite 200
Laval, Quebec H7T 0B3 / CA
Inventor(s)01 / SAMPALIS, Fotini
1348 Elizabeth Boulevard
Laval Quebec H7W 3J8 / CA
02 / HARLAND, Henri
139 rue Ducharme
Rosemere Quebec J7A 4H8 / CA
 [2012/36]
Representative(s)Grund, Martin, et al
Grund Intellectual Property Group
Patentanwälte und Solicitor PartG mbB
Steinsdorfstraße 2
80538 München / DE
[N/P]
Former [2018/08]Grund, Martin, et al
Grund Intellectual Property Group
Patentanwalt und Solicitor PartG mbB
Nikolaistrasse 15
80802 München / DE
Former [2013/04]Grund, Martin, et al
Grund Intellectual Property Group
Nikolaistrasse 15
80802 München / DE
Former [2012/36]Wills, Andrew Jonathan, et al
Mewburn Ellis LLP 33 Gutter Lane London
EC2V 8AS / GB
Application number, filing date10825905.229.10.2010
[2018/08]
WO2010CA01720
Priority number, dateUS20090256106P29.10.2009         Original published format: US 256106 P
[2012/36]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2011050474
Date:05.05.2011
Language:EN
[2011/18]
Type: A1 Application with search report 
No.:EP2493478
Date:05.09.2012
Language:EN
The application published by WIPO in one of the EPO official languages on 05.05.2011 takes the place of the publication of the European patent application.
[2012/36]
Type: B1 Patent specification 
No.:EP2493478
Date:21.02.2018
Language:EN
[2018/08]
Type: B8 Corrected title page of specification 
No.:EP2493478
Date:28.03.2018
[2018/13]
Search report(s)International search report - published on:CA05.05.2011
(Supplementary) European search report - dispatched on:EP28.01.2013
ClassificationIPC:A61K31/683, A61P3/00, A61P9/00
[2012/36]
CPC:
A61K31/685 (EP,CN,IL,KR,RU,US); A61K31/19 (IL,KR,RU); A61K31/683 (EP,CN,IL,RU,US);
A61K31/07 (EP,CN,IL,KR,US); A61K31/122 (EP,CN,IL,KR,US); A61K31/23 (EP,IL,KR,US);
A61K31/352 (EP,CN,IL,US); A61K31/355 (EP,IL,KR,US); A61K45/06 (EP,CN,IL,KR,US);
A61P1/16 (EP,IL,KR); A61P13/12 (EP,IL,KR); A61P19/06 (EP,IL,KR);
A61P21/02 (EP,IL,KR); A61P25/00 (EP,IL); A61P25/02 (EP,IL,KR);
A61P25/14 (EP,IL); A61P25/16 (EP,IL,KR); A61P25/22 (EP,IL,KR);
A61P25/28 (EP,IL,KR); A61P3/00 (EP,IL); A61P3/02 (EP,IL,KR);
A61P3/06 (EP,IL,KR); A61P3/08 (EP,IL,KR); A61P3/10 (EP,IL,KR);
A61P43/00 (EP,IL,KR); A61P5/00 (EP,IL,KR); A61P7/02 (EP,IL,KR);
A61P9/00 (EP,IL,RU); A61P9/04 (EP,IL,KR); A61P9/10 (EP,IL);
A61P9/12 (EP,IL,KR); C07F9/10 (IL,KR,US); A61K2121/00 (IL,KR) (-)
C-Set:
A61K31/07, A61K2300/00 (US,CN,EP);
A61K31/122, A61K2300/00 (US,CN,EP);
A61K31/352, A61K2300/00 (US,CN,EP);
A61K31/683, A61K2300/00 (US,CN,EP);
A61K31/685, A61K2300/00 (CN,EP,US)
(-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2012/36]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:KONZENTRIERTE THERAPEUTISCHE PHOSPHOLIPID-ZUSAMMENSETZUNGEN[2012/36]
English:CONCENTRATED THERAPEUTIC PHOSPHOLIPID COMPOSITIONS[2012/36]
French:COMPOSITIONS DE PHOSPHOLIPIDES THÉRAPEUTIQUES CONCENTRÉES[2012/36]
Entry into regional phase16.05.2012National basic fee paid 
16.05.2012Search fee paid 
16.05.2012Designation fee(s) paid 
16.05.2012Examination fee paid 
Examination procedure16.05.2012Examination requested  [2012/36]
22.08.2013Amendment by applicant (claims and/or description)
29.10.2013Despatch of a communication from the examining division (Time limit: M06)
08.05.2014Reply to a communication from the examining division
24.03.2015Despatch of a communication from the examining division (Time limit: M02)
21.05.2015Reply to a communication from the examining division
02.11.2015Despatch of a communication from the examining division (Time limit: M06)
03.05.2016Reply to a communication from the examining division
14.08.2016Observations by third parties
10.11.2016Despatch of a communication from the examining division (Time limit: M02)
18.01.2017Reply to a communication from the examining division
18.04.2017Despatch of a communication from the examining division (Time limit: M04)
28.06.2017Reply to a communication from the examining division
28.09.2017Communication of intention to grant the patent
18.12.2017Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
18.12.2017Fee for grant paid
18.12.2017Fee for publishing/printing paid
12.01.2018Information about intention to grant a patent
12.01.2018Receipt of the translation of the claim(s)
Divisional application(s)EP18152030.5  / EP3335713
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  29.10.2013
Opposition(s)22.11.2018No opposition filed within time limit [2019/05]
Fees paidRenewal fee
30.10.2012Renewal fee patent year 03
11.10.2013Renewal fee patent year 04
29.10.2014Renewal fee patent year 05
28.10.2015Renewal fee patent year 06
28.10.2016Renewal fee patent year 07
25.10.2017Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU29.10.2010
AL21.02.2018
AT21.02.2018
CY21.02.2018
CZ21.02.2018
EE21.02.2018
HR21.02.2018
LT21.02.2018
LV21.02.2018
MC21.02.2018
MK21.02.2018
PL21.02.2018
RO21.02.2018
RS21.02.2018
SI21.02.2018
SK21.02.2018
SM21.02.2018
TR21.02.2018
BG21.05.2018
GR22.05.2018
IS21.06.2018
IE29.10.2018
LU29.10.2018
MT29.10.2018
[2020/33]
Former [2020/31]HU29.10.2010
AL21.02.2018
AT21.02.2018
CY21.02.2018
CZ21.02.2018
EE21.02.2018
HR21.02.2018
LT21.02.2018
LV21.02.2018
MC21.02.2018
MK21.02.2018
PL21.02.2018
RO21.02.2018
RS21.02.2018
SI21.02.2018
SK21.02.2018
SM21.02.2018
TR21.02.2018
BG21.05.2018
GR22.05.2018
IE29.10.2018
LU29.10.2018
MT29.10.2018
Former [2020/30]HU29.10.2010
AL21.02.2018
AT21.02.2018
CY21.02.2018
CZ21.02.2018
EE21.02.2018
HR21.02.2018
LT21.02.2018
LV21.02.2018
MC21.02.2018
PL21.02.2018
RO21.02.2018
RS21.02.2018
SI21.02.2018
SK21.02.2018
SM21.02.2018
TR21.02.2018
BG21.05.2018
GR22.05.2018
IE29.10.2018
LU29.10.2018
MT29.10.2018
Former [2020/16]AL21.02.2018
AT21.02.2018
CY21.02.2018
CZ21.02.2018
EE21.02.2018
HR21.02.2018
LT21.02.2018
LV21.02.2018
MC21.02.2018
PL21.02.2018
RO21.02.2018
RS21.02.2018
SI21.02.2018
SK21.02.2018
SM21.02.2018
TR21.02.2018
BG21.05.2018
GR22.05.2018
IE29.10.2018
LU29.10.2018
MT29.10.2018
Former [2020/08]AL21.02.2018
AT21.02.2018
CY21.02.2018
CZ21.02.2018
EE21.02.2018
HR21.02.2018
LT21.02.2018
LV21.02.2018
MC21.02.2018
PL21.02.2018
RO21.02.2018
RS21.02.2018
SI21.02.2018
SK21.02.2018
SM21.02.2018
BG21.05.2018
GR22.05.2018
IE29.10.2018
LU29.10.2018
MT29.10.2018
Former [2019/48]AL21.02.2018
AT21.02.2018
CY21.02.2018
CZ21.02.2018
EE21.02.2018
HR21.02.2018
LT21.02.2018
LV21.02.2018
MC21.02.2018
PL21.02.2018
RO21.02.2018
RS21.02.2018
SI21.02.2018
SK21.02.2018
SM21.02.2018
BG21.05.2018
GR22.05.2018
IE29.10.2018
LU29.10.2018
Former [2019/30]AL21.02.2018
AT21.02.2018
CY21.02.2018
CZ21.02.2018
EE21.02.2018
HR21.02.2018
LT21.02.2018
LV21.02.2018
MC21.02.2018
PL21.02.2018
RO21.02.2018
RS21.02.2018
SI21.02.2018
SK21.02.2018
SM21.02.2018
BG21.05.2018
GR22.05.2018
LU29.10.2018
Former [2019/28]AL21.02.2018
AT21.02.2018
CY21.02.2018
CZ21.02.2018
EE21.02.2018
HR21.02.2018
LT21.02.2018
LV21.02.2018
MC21.02.2018
PL21.02.2018
RO21.02.2018
RS21.02.2018
SI21.02.2018
SK21.02.2018
SM21.02.2018
BG21.05.2018
GR22.05.2018
Former [2019/13]AL21.02.2018
AT21.02.2018
CY21.02.2018
CZ21.02.2018
EE21.02.2018
HR21.02.2018
LT21.02.2018
LV21.02.2018
PL21.02.2018
RO21.02.2018
RS21.02.2018
SI21.02.2018
SK21.02.2018
SM21.02.2018
BG21.05.2018
GR22.05.2018
Former [2018/52]AL21.02.2018
AT21.02.2018
CY21.02.2018
CZ21.02.2018
EE21.02.2018
HR21.02.2018
LT21.02.2018
LV21.02.2018
PL21.02.2018
RO21.02.2018
RS21.02.2018
SK21.02.2018
SM21.02.2018
BG21.05.2018
GR22.05.2018
Former [2018/50]AL21.02.2018
AT21.02.2018
CY21.02.2018
CZ21.02.2018
EE21.02.2018
HR21.02.2018
LT21.02.2018
LV21.02.2018
PL21.02.2018
RO21.02.2018
RS21.02.2018
SK21.02.2018
BG21.05.2018
GR22.05.2018
Former [2018/46]AL21.02.2018
AT21.02.2018
CY21.02.2018
HR21.02.2018
LT21.02.2018
LV21.02.2018
RS21.02.2018
BG21.05.2018
GR22.05.2018
Former [2018/40]AT21.02.2018
CY21.02.2018
HR21.02.2018
LT21.02.2018
LV21.02.2018
RS21.02.2018
BG21.05.2018
GR22.05.2018
Former [2018/37]CY21.02.2018
HR21.02.2018
LT21.02.2018
GR22.05.2018
Former [2018/35]CY21.02.2018
HR21.02.2018
LT21.02.2018
Documents cited:Search[Y]WO9739759  (BRIGHAM & WOMENS HOSPITAL [US], et al);
 [Y]JPH10155459  (SUNTORY LTD, et al);
 [Y]WO03072111  (STOLL ANDREW [US]);
 [Y]WO2005011712  (UNIV WASHINGTON [US], et al);
 [Y]WO2005037848  (ENZYMOTEC LTD [IL], et al);
 [Y]US2009118227  (JOUNI ZEINA [US], et al);
 [Y]EP2085089  (KTB TUMORFORSCHUNGS GMBH [DE]);
 [YP]WO2010109330  (UNIV OXFORD [GB], et al)
International search[X]JPH02215351  (TAIYO FISHERY CO LTD);
 [X]JP2000060432  (NIPPON KAGAKU SHIRYO KK);
 [X]WO0023546  (UNIV SHERBROOKE [CA], et al);
 [A]WO02102394  (NEPTUNE TECHNOLOGIES & BIORESS [CA], et al);
 [X]WO03011873  (NEPTUNE TECHNOLOGIES & BIORESS [CA], et al);
 [X]WO2008060163  (PRONOVA BIOPHARMA NORGE AS [NO], et al);
 [X]WO2008117062  (AKER BIOMARINE ASA [NO], et al)
ExaminationGB2290965
 WO2011137160
by applicantWO9739759
 JPH10155459
 WO0023546
 WO02102394
 WO03011873
 WO03072111
 US2004234587
 WO2005011712
 WO2005037848
 US7034168
 WO2008117062
 US2008274203
 US2009074857
 US2009118227
 EP2085089
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.